FDA panel asks for more data on Clovis' lung cancer drug

(Reuters) - An independent panel of experts to the U.S. Food and Drug Administration on Tuesday asked Clovis Oncology Inc for more data on its lung cancer drug before making a final decision on the treatment.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro